OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
LPGI$690.0055

Lippo General Insurance Tbk PT

Life & Health InsuranceVerified

Lippo General Insurance Tbk PT maintains a strong liquidity position, as evidenced by a price-to-book ratio of 2.01 and a price-to-tangible-book ratio of 2.01, indicating that the company's market value is trading at a premium to its book value. The company's operating cash flow of 505,352,898,010 IDR and free cash flow of 118,493,595,790 IDR suggest robust cash generation capabilities, which support its liquidity and financial flexibility. In terms of profitability, the company's return on equity (ROE) of 14.08% and return on assets (ROA) of 4.64% outperform the typical benchmarks for the Life & Health Insurance industry, which often hover around 10% ROE and 3-4% ROA. The company's net income of 144,731,453,090 IDR and operating income of 161,930,558,700 IDR further underscore its strong earnings performance. The company's revenue is concentrated within the Indonesian market, as disclosed segments do not indicate significant geographic diversification. This concentration may expose the company to local economic and regulatory risks, although no immediate filing-based liquidity or dilution flags were detected. Looking ahead, the company is projected to maintain its growth trajectory, supported by its strong cash flow and profitability. The absence of long-term debt and a debt-to-equity ratio of 0.0 indicate a conservative capital structure, which may support stable earnings and reduce financial risk. The company's risk profile is characterized by low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The absence of long-term debt and a strong equity base further mitigate financial risk. Additionally, the company's capital expenditure of -24,934,263,440 IDR suggests a focus on cost efficiency and asset optimization. Recent filings and transcripts do not indicate any significant events that would alter the company's current financial or operational trajectory. The company's financial health and strategic positioning appear to be stable, with no immediate concerns regarding liquidity or dilution.

30-day price · LPGI+30.00 (+4.5%)
Low$600.00High$780.00Close$700.00As of12 May, 00:00 UTC
Profile
CompanyLippo General Insurance Tbk PT
TickerLPGI.JK
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Lippo General Insurance Tbk PT provides life and health insurance products in Indonesia, generating revenue primarily through premium income and investment returns on its insurance reserves.

Classification. Lippo General Insurance Tbk PT is classified under the Life & Health Insurance industry within the Financials sector, with a high confidence level of 0.92 based on verified market data.

Lippo General Insurance Tbk PT maintains a strong liquidity position, as evidenced by a price-to-book ratio of 2.01 and a price-to-tangible-book ratio of 2.01, indicating that the company's market value is trading at a premium to its book value. The company's operating cash flow of 505,352,898,010 IDR and free cash flow of 118,493,595,790 IDR suggest robust cash generation capabilities, which support its liquidity and financial flexibility. In terms of profitability, the company's return on equity (ROE) of 14.08% and return on assets (ROA) of 4.64% outperform the typical benchmarks for the Life & Health Insurance industry, which often hover around 10% ROE and 3-4% ROA. The company's net income of 144,731,453,090 IDR and operating income of 161,930,558,700 IDR further underscore its strong earnings performance. The company's revenue is concentrated within the Indonesian market, as disclosed segments do not indicate significant geographic diversification. This concentration may expose the company to local economic and regulatory risks, although no immediate filing-based liquidity or dilution flags were detected. Looking ahead, the company is projected to maintain its growth trajectory, supported by its strong cash flow and profitability. The absence of long-term debt and a debt-to-equity ratio of 0.0 indicate a conservative capital structure, which may support stable earnings and reduce financial risk. The company's risk profile is characterized by low liquidity and dilution risks, with no immediate filing-based liquidity or dilution flags detected. The absence of long-term debt and a strong equity base further mitigate financial risk. Additionally, the company's capital expenditure of -24,934,263,440 IDR suggests a focus on cost efficiency and asset optimization. Recent filings and transcripts do not indicate any significant events that would alter the company's current financial or operational trajectory. The company's financial health and strategic positioning appear to be stable, with no immediate concerns regarding liquidity or dilution.
Key takeaways
  • Lippo General Insurance Tbk PT has a strong liquidity position, supported by high operating and free cash flows.
  • The company's ROE and ROA are above industry benchmarks, indicating superior profitability.
  • The company's revenue is concentrated in Indonesia, which may expose it to local economic and regulatory risks.
  • The company maintains a conservative capital structure with no long-term debt and a low debt-to-equity ratio.
  • No immediate liquidity or dilution risks were detected, and the company's risk profile is considered low.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue
Gross profit
Operating income$161.93B
Net income$144.73B
R&D
SG&A
D&A
SBC
Operating cash flow$505.35B
CapEx-$24.93B
Free cash flow$118.49B
Total assets$3.12T
Total liabilities$2.09T
Total equity$1.03T
Cash & equivalents
Long-term debt$0.00
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$690.00
Market cap$2.07T
Enterprise value
P/E14.3
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B2.0
P/Tangible book2.0
Tangible book$1.03T
Net cash
Current ratio
Debt/Equity0.0
ROA4.6%
ROE14.1%
Cash conversion3.5%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Life & Health Insurance · cohort 1 companies
MetricLPGIActivity
Op margin21.1% medp25 16.7% · p75 136.5%
Net margin10.4% medp25 5.7% · p75 19.8%
Gross margin21.0% medp25 21.0% · p75 21.0%
CapEx / revenue2.4% medp25 2.4% · p75 2.4%
Debt / equity0.0%48.5% medp25 43.7% · p75 53.3%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 13:25 UTC#26da14d7
Market quoteclose IDR 690.00 · shares 3.00B diluted
no public URL
2026-05-10 13:25 UTC#85d837ff
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 13:26 UTCJob: 29c3a013